{"protocolSection":{"identificationModule":{"nctId":"NCT00361530","orgStudyIdInfo":{"id":"J-STARS echo"},"secondaryIdInfos":[{"id":"C000000212","type":"OTHER","domain":"UMIN CTR"}],"organization":{"fullName":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","class":"OTHER"},"briefTitle":"Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)","officialTitle":"Effect of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Upon Carotid Intima-media Complex Thickness in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS."},"statusModule":{"statusVerifiedDate":"2016-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2004-03"},"primaryCompletionDateStruct":{"date":"2014-07","type":"ACTUAL"},"studyFirstSubmitDate":"2006-08-07","studyFirstSubmitQcDate":"2006-08-07","studyFirstPostDateStruct":{"date":"2006-08-08","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-04-22","lastUpdatePostDateStruct":{"date":"2016-04-25","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","class":"OTHER"},"collaborators":[{"name":"Ministry of Health, Labour and Welfare, Japan","class":"OTHER_GOV"},{"name":"Hiroshima University","class":"OTHER"},{"name":"National Cerebral and Cardiovascular Center, Japan","class":"OTHER"}]},"descriptionModule":{"briefSummary":"Carotid ultrasound can reveal the intima-media complex thickness(IMT), that has been reported to be a marker of atherosclerosis as well as a risk of cardiovascular events, and to be attenuated by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) . This substudy of J-STARS will observe the temporal profile of carotid IMT prospectively in the patients with prescription of pravastatin and the control."},"conditionsModule":{"conditions":["Ischemic Stroke"],"keywords":["stroke","brain ischemia","cerebrovascular accident","statin","hydroxymethylglutaryl-CoA Reductase Inhibitors","cholesterol","hypercholesterolemia","hyperlipidemia","multicenter studies","prospective studies","endpoint determination","randomized controlled trials","recurrence","pravastatin","plaque","tunica intima","tunica media","ultrasonography","carotid arteries"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":854,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Pravastatin","type":"ACTIVE_COMPARATOR","description":"Patient has 10mg oral administration of Pravastatin per day. It starts within one month from their entry and continues every day until the end of the study or its endpoints.","interventionNames":["Drug: Statin"]},{"label":"No intervention","type":"NO_INTERVENTION","description":"Patient has no intervention."}],"interventions":[{"type":"DRUG","name":"Statin","armGroupLabels":["Pravastatin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Intima-media complex thickness (IMT) of the common carotid artery (CCA)","timeFrame":"until the last day of the next February after 5-year follow-up survey"}],"secondaryOutcomes":[{"measure":"Plaque score, number of plaque, recurrent cerebrovascular events","timeFrame":"until the last day of the next February after 5-year follow-up survey"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ischemic stroke except for cardiogenic embolism, from 1 month to 3 years after onset\n* Hyperlipidemia and total cholesterol level of 180-240mg/dl without the prescription of statin within previous 30 days\n* Able to visit outpatient department\n* Informed consent on the form.\n\nExclusion Criteria:\n\n* Ischemic stroke of other determined cause according to the TOAST classification\n* Ischemic heart disease and necessary to use statin\n* Hemorrhagic disorders\n* Platelet count \\<=100,000/ul within 3 months prior to study start\n* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST)\\>= 100IU/L within 3 months prior to study start\n* Serum creatinine \\>=2.0mg/dl within 3 months prior to study start\n* A scheduled operation\n* The presence of malignant disorder\n* Patients whom carotid ultrasound cannot examine because of neck tumor or torticollis\n* Patients after carotid endarterectomy or radiation therapy to neck\n* Patients whose carotid ultrasound cannot be examined because of neck tumor or torticollis\n* Patients after carotid endarterectomy or radiation therapy to neck","healthyVolunteers":false,"sex":"ALL","minimumAge":"45 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Masayasu Matsumoto, MD, PhD","affiliation":"Hiroshima University Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"National Cardiovascular Center (NCVC)","city":"Suita-shi","state":"Osaka","zip":"565-0873","country":"Japan","geoPoint":{"lat":34.76143,"lon":135.51567}},{"facility":"Hiroshima University Hospital","city":"Hiroshima","zip":"734-8551","country":"Japan","geoPoint":{"lat":34.4,"lon":132.45}}]},"referencesModule":{"references":[{"pmid":"31035902","type":"DERIVED","citation":"Wada S, Koga M, Minematsu K, Toyoda K, Suzuki R, Kagimura T, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Matsumoto M. Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin. Stroke. 2019 Jun;50(6):1586-1589. doi: 10.1161/STROKEAHA.119.024968. Epub 2019 Apr 30."},{"pmid":"29191850","type":"DERIVED","citation":"Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; J-STARS Investigators. Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke). Stroke. 2018 Jan;49(1):107-113. doi: 10.1161/STROKEAHA.117.018387. Epub 2017 Nov 30."}],"seeAlsoLinks":[{"label":"Related Info","url":"http://jstars.umin.ne.jp"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M14540","name":"Recurrence","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9690","name":"Hyperlipidemias","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M9678","name":"Hypercholesterolemia","relevance":"LOW"},{"id":"M9692","name":"Hyperlipoproteinemias","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M20845","name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","relevance":"LOW"},{"id":"M19058","name":"Pravastatin","relevance":"LOW"}],"browseBranches":[{"abbrev":"Lipd","name":"Lipid Regulating Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}